Airway Obstruction Management and Therapeutic Interventions

Airway obstruction encompasses a spectrum of disorders characterised by partial or complete narrowing of the central or peripheral airways, leading to dyspnoea, impaired gas exchange and, in severe cases, life-threatening respiratory failure. Management strategies range from pharmacological modulation of inflammation and fibrosis to minimally invasive endoscopic procedures and open surgical reconstruction. Endoscopic dilation, laser ablation and stent placement offer rapid relief of luminal narrowing, while surgical techniques such as cricotracheal resection and segmental tracheal resection provide definitive correction in refractory cases. Recent advances in device engineering have yielded bioresorbable and customised stents with tunable mechanical properties, reducing the need for repeated interventions. Parallel progress in understanding fibroinflammatory pathways has opened avenues for targeted molecular therapies aimed at modulating aberrant wound healing. Successful airway management now rests on an integrated approach that aligns patient-specific anatomical factors with the biological drivers of stenosis. Innovations in imaging, 3D printing and endobronchial drug delivery are poised to refine therapeutic algorithms, minimise complications and extend benefits to diverse patient populations worldwide.

Research from Nature Portfolio

Recent studies have established an experimental model of post-intubation tracheal stenosis in large animals, demonstrating that excessive cuff pressure and over-sized tubes provoke submucosal inflammation, granulation tissue hyperplasia and cartilage collapse. This work has characterised the biomechanical thresholds that initiate fibroinflammatory remodelling and defined histopathological hallmarks akin to clinical stenosis. By elucidating the relationship between mechanical insult and mucosal repair, this model provides a robust platform for preclinical evaluation of anti-fibrotic agents and novel stent prototypes, thereby bridging fundamental pathophysiology with translational therapeutic development.

Airway Obstruction Management and Therapeutic Interventions publication trend

The graph below shows the total number of articles in airway obstruction management and therapeutic interventions across all publications each year (not limited to Nature Index journals).

Technical terms

Idiopathic subglottic stenosis: A narrowing of the airway below the vocal cords without identifiable cause, characterised by mucosal inflammation and concentric fibrosis.

Endoscopic dilation: A minimally invasive procedure in which balloon or rigid dilators are introduced via an endoscope to widen a stenotic airway segment.

Bioresorbable stent: A temporary implant designed to prop open an airway lumen and gradually degrade into biocompatible by-products, eliminating the need for removal.

Fibroinflammatory scarring: The combined process of inflammation and fibrotic tissue deposition that leads to pathological narrowing of airways following injury.

Cricotracheal resection: A surgical technique involving removal of a diseased segment encompassing the cricoid cartilage and adjacent trachea, with primary anastomosis to restore patency.

References

1. A canine model of tracheal stenosis induced by cuffed endotracheal intubation. Scientific Reports (2017).
2. Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults. International Journal of Molecular Sciences (2022).
3. Digital light 3D printing of customized bioresorbable airway stents with elastomeric properties. Science Advances (2021).
4. Endoscopic Treatment of Idiopathic Subglottic Stenosis: A Systematic Review. Frontiers in Surgery (2020).